Glaxosmithkline



Ebitda Zmiana Data
AbbVie USD 6.92B 258M 2024-12
Amgen USD 3.75B 42M 2025-03
AstraZeneca USD 5.08B 182M 2025-03
Aurora Cannabis CAD -25369000 7.78M 2024-12
Bausch Health Companies USD 597M 256M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Canopy Growth CAD -8628000 2.1M 2024-12
Corcept Therapeutics USD 3.88M 21.66M 2025-03
Drreddys Laboratories INR 23.31B 1.4B 2024-12
Eli Lilly USD 4.16B 2B 2025-03
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Indivior 72M 34M 2025-03
J&J USD 7.88B 1.76B 2025-03
Merck USD 7.74B 625M 2025-03
Novartis USD 5.19B 319M 2024-12
Pacira USD 29.34M 21.43M 2025-03
Perrigo USD 245.1M 49.4M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Prestige Brands USD 108.15M 9.32M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 2.86B 2.3B 2025-03
Supernus Pharmaceuticals USD 49.15M 11.8M 2024-12
Takeda JPY 128.14B 126.45B 2025-03
Teva Pharmaceutical Industries USD 1.11B 848M 2025-03
Zoetis USD 968M 74M 2025-03



Glaxosmithkline - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.